Cardiokine's Acquisition

Cardiokine was acquired by Cornerstone Therapeutics on December 22, 2011.

CardioKine develops pharmaceuticals for cardio-renal diseases. Their lead product lixivaptan is a sodium-sparing diuretic for the treatment of heart failure and electrolyte imbalances. In Decembe…

Articles about Cardiokine's Acquisition: